A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity
Public ClinicalTrials.gov record NCT06595238. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Obesity or Overweight With Comorbidity
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 compared with placebo, given once a week as subcutaneous injection for 36 weeks, in male and female participants of at least 18 years of age who are living with obesity (body mass index \[BMI\] ≥ 30 kg/m2), or overweight (BMI ≥ 27 kg/m2) and at least one weight-related comorbidity
Study identification
- NCT ID
- NCT06595238
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 262 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 1, 2024 (Actual)
- Primary completion
- Dec 3, 2025 (Actual)
- Completion
- Dec 3, 2025 (Actual)
- Last update posted
- Oct 2, 2026
2024 – 2025
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Mobile | Alabama | 36608 | — |
| Research Site | Phoenix | Arizona | 85044 | — |
| Research Site | Long Beach | California | 90815 | — |
| Research Site | Hialeah | Florida | 33012 | — |
| Research Site | Largo | Florida | 33777 | — |
| Research Site | Orlando | Florida | 32825 | — |
| Research Site | Tampa | Florida | 33606 | — |
| Research Site | Woodstock | Georgia | 30189 | — |
| Research Site | Indianapolis | Indiana | 46260 | — |
| Research Site | Lutherville-Timonium | Maryland | 21093 | — |
| Research Site | Gulfport | Mississippi | 39503 | — |
| Research Site | Ridgeland | Mississippi | 39157 | — |
| Research Site | Kansas City | Missouri | 64111 | — |
| Research Site | Omaha | Nebraska | 68134 | — |
| Research Site | Portsmouth | New Hampshire | 03801 | — |
| Research Site | Statesville | North Carolina | 28625 | — |
| Research Site | North Charleston | South Carolina | 29405 | — |
| Research Site | Knoxville | Tennessee | 37938 | — |
| Research Site | Austin | Texas | 78731 | — |
| Research Site | Dallas | Texas | 75230 | — |
| Research Site | Port Arthur | Texas | 77642 | — |
| Research Site | San Antonio | Texas | 78231 | — |
| Research Site | San Antonio | Texas | 78249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06595238, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 2, 2026 · Synced Nov 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06595238 live on ClinicalTrials.gov.